Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03539107
Other study ID # Popiel02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2019
Est. completion date December 20, 2019

Study information

Verified date January 2020
Source Yale University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare voiding assessment based on a minimum spontaneous voided volume of 150 cc with the standard retrograde fill approach in women after pelvic floor procedures.


Recruitment information / eligibility

Status Completed
Enrollment 110
Est. completion date December 20, 2019
Est. primary completion date December 20, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All 18-year-old or older women who undergo surgery for urinary incontinence and/or pelvic organ prolapse (POP)

Exclusion Criteria:

- Patients who require prolonged Foley catheter or suprapubic catheter

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Retrograde bladder fill
Subjects will have their bladder retrograde filled with 300mL of fluid prior to a voiding trial.
Other:
spontaneous void
Subjects will not have retrograde fill of bladder, rather will be required to void 150 mL spontaneously prior to discharge.

Locations

Country Name City State
United States Yale University New Haven Connecticut

Sponsors (1)

Lead Sponsor Collaborator
Yale University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Failure rate The percentage of subjects who did not meet the required voiding assessment criteria and needed catheterization . Up to 2 days post op
Secondary False pass rate The percentage of women who initially met the voiding assessment but returned for re-catheterization due to voiding difficulty . up to 30 days after discharge.
Secondary Force of stream (FOS) Patient reported force of stream (FOS) during voiding; (0 being no urination, 10 being normal strong flow). Up to 2 days post op.
Secondary Force of stream (FOS) Patient reported force of stream (FOS) during voiding; (0 being no urination, 10 being normal strong flow). Up to 2 days post-surgery.
Secondary Patient Satisfaction Questionnaire for Voiding Assessment-method used This question asks "How satisfied were you with the method we used to evaluate how well you could urinate after our surgery?" It is measured on a continuum from 0 (very dissatisfied) to 100 (very satisfied). Up to 2 days post-surgery.
Secondary Patient Satisfaction Questionnaire for Voiding Assessment-negative emotions This question asks "Did you experience any negative emotions such as fear or anxiety when we were evaluating urination after our surgery?" It is measured on a continuum from 0 (many negative emotions) to 100 (no negative emotions). Up to 2 days post-surgery.
Secondary Patient Satisfaction Questionnaire for Voiding Assessment-recommend method This question asks "How likely would you be to recommend to a friend or family member, the method we used to evaluate your urination after our surgery, if they were in the same situation?" It is measured on a continuum from 0 (very unlikely) to 100 (very likely). Up to 2 days post-surgery.
Secondary Patient Satisfaction Questionnaire for Voiding Assessment-convenience of method This question asks "How convenient was the method we used to evaluate your urination after our surgery (e.g. time, ease etc.)? It is measured on a continuum from 0 (very inconvenient) to 100 (very convenient). Up to 2 days post-surgery.
Secondary Patient Satisfaction Questionnaire for Voiding Assessment-preferred method This question asks the patient: "If it was all up to you, which It is measured on a continuum from 0 (strongly prefer backfill before catheter) to 100 (strongly prefer no backfill before catheter removal). Up to 2 days post-surgery.
Secondary Postoperative pain score This outcome is measured by a 10-point visual analog scale where 0= no pain, 10=worst pain you have ever experienced. One day post-surgery.
Secondary Urinary tract infection (UTI) UTI is defined as culture-proven bladder infection or, in the absence of a culture, clinical suspicion of a bladder infection that resulted in treatment. Up to 30 days post surgery.
Secondary Post-operative complications Post-operative complications assessed by medical record review. Up to 30 days post-surgery.
Secondary Length of hospital stay Length of hospital stay assessed by medical record review. Up to 2 days post-surgery.
See also
  Status Clinical Trial Phase
Recruiting NCT05534412 - A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence N/A
Recruiting NCT05515198 - Improving Care for Women With Urinary Incontinence (EMPOWER) N/A
Completed NCT04071301 - Collection of Real-life Measurement Data for TENA SmartCare Change Indicator in Subjects With Urinary Incontinence N/A
Completed NCT03623880 - Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders N/A
Recruiting NCT05880862 - Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls Early Phase 1
Recruiting NCT04159467 - Effect of Pelvic Floor Muscle Training on Urinary Incontinence Reports in Obese Women Undergoing a Low Calorie Diet N/A
Completed NCT05485922 - Performance of a Single-use Intermittent Micro-hole Zone Catheter N/A
Completed NCT06268782 - The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women N/A
Not yet recruiting NCT03027986 - Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy N/A
Recruiting NCT02490917 - ACT™ Balloons Versus Artificial Urinary Sphincter (AMS800™) for the Treatment of Female Stress Urinary Incontinence N/A
Enrolling by invitation NCT02530372 - Feasibility of the UriCap-F for Urine Collection in Hospitalized Women N/A
Enrolling by invitation NCT02529371 - Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients N/A
Completed NCT02549729 - Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy N/A
Completed NCT02600676 - Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis N/A
Completed NCT02338726 - Pelvic Floor Symptoms and Quality of Life in Elderly Women - a Population-based Pilot Study N/A
Completed NCT02368262 - Prevalence of Incontinence and Risk Factors in Children With Cerebral Palsy N/A
Completed NCT02239796 - Feasibility Controlled Trial of Tibial Nerve Stimulation for Stroke Related Urinary Incontinence N/A
Completed NCT01942681 - Female Patients With Signs of uRgE and Stress Urinary Incontinence Study of Propiverine Hydrochloride N/A
Recruiting NCT01804153 - Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO) Phase 1/Phase 2
Completed NCT01520948 - Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease Phase 3